These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30467061)
1. Immunization with attenuated non-transformable pneumococcal pep27 and comD mutant provides serotype-independent protection against pneumococcal infection. Kim SJ; Seon SH; Luong TT; Ghosh P; Pyo S; Rhee DK Vaccine; 2019 Jan; 37(1):90-98. PubMed ID: 30467061 [TBL] [Abstract][Full Text] [Related]
2. Pneumococcal pep27 mutant immunization stimulates cytokine secretion and confers long-term immunity with a wide range of protection, including against non-typeable strains. Kim GL; Choi SY; Seon SH; Lee S; Park SS; Song JY; Briles DE; Rhee DK Vaccine; 2016 Dec; 34(51):6481-6492. PubMed ID: 27865564 [TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice. Kim EH; Choi SY; Kwon MK; Tran TD; Park SS; Lee KJ; Bae SM; Briles DE; Rhee DK Vaccine; 2012 Mar; 30(11):2008-19. PubMed ID: 22154770 [TBL] [Abstract][Full Text] [Related]
4. Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With Jang AY; Ahn KB; Zhi Y; Ji HJ; Zhang J; Han SH; Guo H; Lim S; Song JY; Lim JH; Seo HS Front Immunol; 2019; 10():1212. PubMed ID: 31191555 [No Abstract] [Full Text] [Related]
5. Intranasal Immunization with the Commensal Shekhar S; Khan R; Schenck K; Petersen FC Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742 [No Abstract] [Full Text] [Related]
6. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice. Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468 [TBL] [Abstract][Full Text] [Related]
10. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Roche AM; King SJ; Weiser JN Infect Immun; 2007 May; 75(5):2469-75. PubMed ID: 17339359 [TBL] [Abstract][Full Text] [Related]
11. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization. Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602 [TBL] [Abstract][Full Text] [Related]
12. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease. Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319 [TBL] [Abstract][Full Text] [Related]
13. Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments. Lu J; Guo J; Wang D; Yu J; Gu T; Jiang C; Kong W; Wu Y Hum Vaccin Immunother; 2019; 15(2):371-380. PubMed ID: 30235046 [TBL] [Abstract][Full Text] [Related]
14. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice. Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043 [TBL] [Abstract][Full Text] [Related]